TAYLOR BEN R (Chief Financial Officer) received a stock award from RECURSION PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 2/10/2026ACC: 0001601830-26-000013
Officer· Chief Financial Officer
Since Feb 2026
+459.13K
Net shares
Net buyer
$45.4K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
470.53K acquired · 11.40K disposed
Non-Derivative Transactions3
Class A Common Stock
Direct
Shares
+446.28K
Price / share
—
Trade value
—
% of position
58.6%
2/6/2026
761.55K→1.21M
Class A Common Stock
Direct
Shares
+24.25K
Price / share
—
Trade value
—
% of position
2.0%
2/6/2026
1.21M→1.23M
Class A Common Stock
Direct
Shares
−11.40K
Price / share
$3.98
Trade value
$45.37K
% of position
0.9%
2/6/2026
1.23M→1.22M
Total
Net shares
+459.13K
Net value
-$45.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/6/2026 | A · Award | +446.28K | — | — | 58.6% | 761.55K | 1.21M |
| Class A Common Stock Direct | 2/6/2026 | A · Award | +24.25K | — | — | 2.0% | 1.21M | 1.23M |
| Class A Common Stock Direct | 2/6/2026 | F · Tax Withholding | −11.40K | $3.98 | $45.37K | 0.9% | 1.23M | 1.22M |
| Total | +459.13K | -$45.37K | ||||||
Derivative Transactions0
No derivative transactions reported